Creating new methods to identify cancer markers
DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
This study is exploring new ways to identify special markers in the body that can help doctors diagnose and treat cancer better, so patients can receive more personalized and effective care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10281338 on NIH RePORTER |
What this research studies
This research focuses on developing advanced methods to characterize novel cancer biomarkers, which are biological indicators that can help in the diagnosis and treatment of cancer. By utilizing innovative molecular techniques, the project aims to enhance the understanding of these biomarkers and their role in cancer progression. Patients may benefit from improved diagnostic tools and targeted therapies that arise from this research, leading to more personalized treatment options. The approach involves rigorous testing and validation of these biomarkers in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who may benefit from new diagnostic methods and targeted therapies.
Not a fit: Patients with non-malignant conditions or those who do not have cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnoses and more effective, personalized treatment options for patients.
How similar studies have performed: Other research has shown success in developing biomarkers for cancer, indicating that this approach has potential for significant advancements in cancer treatment.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Dmitrovsky, Ethan — Leidos Biomedical Research, INC.
- Study coordinator: Dmitrovsky, Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.